BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lactiplantibacillus pentosus {L. pentosus} - unclassified Escherichia |
👶
Synbiotic (Lactiplantibacillus pentosus GSSK2 and isomalto-oligosaccharides) supplementation modulates pathophysiology and gut dysbiosis in experimental metabolic syndrome. Scientific reports (Sci Rep ) Vol: 11 Issue 1 Pages: 21397 Pub: 2021 Nov 1 Epub: 2021 Nov 1 Authors Khanna S , Bishnoi M , Kondepudi KK , Shukla G , Html Article Publication |
| Lactiplantibacillus pentosus {L. pentosus} - unclassified Escherichia |
👶
An exopolysaccharide from Lactobacillus pentosus YY-112: structure and effect on the human intestinal microbiota. Food & function (Food Funct ) Vol: 14 Issue 16 Pages: 7718-7726 Pub: 2023 Aug 14 Epub: 2023 Aug 14 Authors Yang Y , Wang M , Zhang H , Zhou W , Liu W , Pi X , Xing J , Publication |
| Lactiplantibacillus pentosus {L. pentosus} - unclassified Escherichia |
👶
Potential prebiotic properties of exopolysaccharides produced by a novel Lactobacillus strain, Lactobacillus pentosus YY-112. Food & function (Food Funct ) Vol: 12 Issue 19 Pages: 9456-9465 Pub: 2021 Oct 4 Epub: 2021 Oct 4 Authors Wang M , Zhou W , Yang Y , Xing J , Xu X , Lin Y , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
